Slocum, Gordon & Co’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Slocum, Gordon & Co's BMY Position: Q3 2026 in Review
Slocum, Gordon & Co held its Bristol-Myers Squibb (BMY) position steady in Q3 2026 at 3,646 shares worth $228K. The position accounts for 0.16% of the portfolio, ranked #63.
Slocum, Gordon & Co first reported a position in BMY in Q4 2022 and has held it in 14 quarters since. The position peaked at $283K in Q1 2025. 2,570 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- Slocum, Gordon & Co held 3,646 shares of Bristol-Myers Squibb worth $228K as of Q3 2026.
- Slocum, Gordon & Co left its Bristol-Myers Squibb share count unchanged in Q3 2026.
- Bristol-Myers Squibb made up 0.16% of Slocum, Gordon & Co's portfolio in Q3 2026, its #63 holding.
- Slocum, Gordon & Co first reported a position in Bristol-Myers Squibb in Q4 2022 and has held it in 14 quarters since.
- Slocum, Gordon & Co's Bristol-Myers Squibb position peaked at $283K in Q1 2025.
- 2,570 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on Slocum, Gordon & Co's 13F filing for Q3 2026, filed 19 Oct 2026.